Neutrophil CD64 (nCD64) is one of the most researchable sepsis biomarkers; it shows a valuable role in both diagnosing and monitoring infections in both early-onset and late-onset sepsis in either term or preterm newborns [4, 6, 9–13]. This evidence concerns the gene FCGR1A and Sepsis.